Kirby, Fiona and Mel · Corporate leadership, community service and shared experience.
Kirby de Lanerolle
Co-founder & CEO · Conscience IQ
Kirby leads Conscience IQ, bringing together his work in human performance, psychology and neuroscience. Alongside Fiona, he oversees churches through WOWLife and the Apostolic Diocese of Ceylon. His experience spans organizational leadership, community development and public service.
Academic background MSc, Psychology & Neuroscience — King’s College London.
Fiona brings a background in law, organizational development and human performance to Conscience IQ. She co-founded the Warehouse Project and, alongside Kirby, oversees churches through WOWLife. Her experience includes business, creative direction, community development and endurance sport.
Academic background LLB (Hons) — University of Buckingham. Master’s in Theology — Fuller Theological Seminary. Certified High Flow Coach.
Mel serves as International Administrative Director of WOW LIFE WORLD and a Board Director of the Warehouse Project. Her experience spans operations, project delivery and community development, including youth education and social empowerment.
Academic background BSc, Anthropology and Politics — Oxford Brookes University. Master’s in Global Cultures — King’s College London.
Our wider work spans Conscience IQ, Rapha Ltd and community leadership. Here, we contribute as fellow users and supporters of access to information.
We are peptide users and supporters of better information. We started Peptide Observatory for the sake of others: to make reports, experiences and evidence easier to find and understand.
As users ourselves, we are concerned about how unsafe parts of this industry have become. Unclear product quality, incomplete information and accounts of harm leave people trying to make decisions without a clear picture. We want to be there for those people, helping them see what has been reported and what remains uncertain.
We contribute from our own backgrounds and experience as users. Our support for informed research is not a claim that every peptide or product is safe. Personal experience does not establish clinical safety, and the Observatory does not replace individual medical advice.
KEEPING THE OBSERVATORY RUNNING
A small fee for a shared resource.
The USD 2.99 monthly membership fee is intended to cover retrieving information and the costs of hosting, maintenance and keeping the site running. Our purpose is to help others access information about reported benefits, harms and uncertainties.
Membership payments are not open yet. You can register your interest without being charged.
USD 2.99per month
THE SAFETY OBSERVATORY
We want you to be safe while using peptides.
This site collects anecdotal reports from social media alongside research to help you understand reported benefits, harms and uncertainty. Updates every week from social media anecdotes.
Source review 12 September 2026
ANECDOTAL REPORTS
Reported incidents by month and peptide
These charts count selected adverse-event reports, not every collected post or comment. Publication dates are not necessarily incident dates.
Unverified anecdotes
13 selected adverse-event reports = 2 dated 2026 + 4 from earlier years + 7 with unresolved dates. All are included in the default peptide chart; only dated 2026 records can be placed on the monthly chart.
2Dated 2026 reports
Feb & MayMost reports: 1 per month · tied
7Unresolved dates · included below
2026 reports by publication month · 2 reports
0 = no dated report in this collection, not no incidents. The current month is partial; future months are outside the collection period.
2026 incident reports by platform
2 reports · the same dated reports as the monthly chart
Reddit · 2
Each report is counted once by platform. General discussion, questions and promotional posts in the collected-post totals are not counted as incidents.
Reports per peptide
All dates, including unresolved dates · 13 source records
Y-axis · Anecdotal incident reports
X-axis · Peptides
Most named: MOTS-C (5 each). A combination report counts once in the monthly total and once for each named peptide. This does not identify which compound caused the event or rank danger.
Verification status · all reports
13 source records · independent clinical verification
No independent clinical verification documented · 13
Independently clinically verified · 0
The collection currently contains no documented independent clinical verification. Reading a source, reviewing a submission or automatically screening text does not confirm diagnosis or causation. All reports are included in the peptide chart when no month is selected.
Date coverage · all reports
Every source record appears once here, including reports that cannot be assigned to a month.
Author reports severe tongue/throat swelling and breathing difficulty after combined exposure. Ambulance care and four epinephrine injections reported.
Author reports hives, low blood pressure, fainting, sweating and increased pulse. About 45 minutes of symptoms reported; no emergency treatment stated.
PO-S013 · Facebook · Event date: “Last night” in post; exact date unknown
Anecdotal, selected public posts and comments; clinical diagnosis and causality unverified. These are report counts, not incidence rates or unique patient counts. Publication month may differ from event month. Reports with missing or conflicting dates are included in the all-dates peptide chart and source register, but excluded from the monthly chart. Counts across peptides can exceed the source-record total because a report may name more than one peptide.
Built around traceable evidence. 13 public posts and comments are indexed alongside FDA sources. See Sources & coverage for automated collection status.
Certificate records 04Issuer authentication incomplete
Batch safety certification Not availableAbsence of reports ≠ safety
PUBLIC POSTS & COMMENTS
First-hand safety signals
13 source records
Initial collection plus reviewed and automatically screened imports
Reddit
6
Instagram
4
TikTok
0
YouTube
0
ExcelMale
2
Facebook
1
7 comments + 6 original posts. Selected for adverse-event content; not a representative sample, incidence rate or confirmed case count.
Initial collection access limits are documented under Sources & coverage.
PRIORITY SAFETY SIGNALS
Some questions cannot wait.
Anaphylaxis, collapse and serious biological hazards need clinical assessment, not a forum consensus.
If someone has trouble breathing or collapses, contact local emergency services immediately. Do not wait for a report review.
Peptide evidence directory
What the sources say. What remains unknown.
13 of 13 molecules
⌕
Peptide
Evidence signal
Primary concern
Public accounts
FDA reports¹
Regulatory safety signal
Dosing errors · gastrointestinal events
990
Regulatory safety signal
Dose escalation · product authenticity
>730
Safety evidence limited
Immune response · purity uncertainty
—
Regulatory safety signal
Increased heart rate · vasodilation
—
Safety evidence limited
Immune response · uncertain causality
—
Unapproved product concern
Unapproved online products
—
Anecdotal · unverified
Public self-report · causality unresolved
—
Anecdotal · unverified
Public self-report · causality unresolved
—
Anecdotal · unverified
Public self-report · causality unresolved
—
Anecdotal · unverified
Public self-report · causality unresolved
—
Anecdotal · unverified
Public self-report · causality unresolved
—
Anecdotal · unverified
Public self-report · causality unresolved
—
Anecdotal · unverified
Public self-report · causality unresolved
—
¹ FDA reports for compounded products, as of 31 May 2026. Not incidence, confirmed causality or a comparison of risk. — = unavailable.
PUBLIC POSTS & COMMENTS
Collection & review statistics
Some posts and comments are found and collected automatically by a bot for convenience. Automated collection does not verify the author, product, reported experience or claim.
Loading collection…
PURPOSE & TRANSPARENCY
Peptide controversies, with the uncertainty visible.
Our aim is to bring together posts about peptide controversies, grievances and reported side effects on one page, so people can inspect the original sources and make better-informed judgments. We seek broad coverage, but cannot guarantee that every post is captured.
Some posts and comments are searched for and collected automatically by a bot for convenience. Inclusion does not mean endorsement or confirmation. Collection counts, review status and documented verification status are displayed openly above; unverified accounts remain labelled as such.
Verification remains the reader’s responsibility
Peptide Observatory does not undertake to independently verify every post or comment and does not guarantee the accuracy, authenticity or completeness of third-party claims. We accept no responsibility for verifying those claims. A source link, review label or certificate record does not establish that a reported event occurred as described, or that a peptide caused it.
Share your experience with integrity
We welcome honest reports of grievances, suspected side effects and other peptide experiences. Describe what you personally observed, distinguish facts from suspicion, and include dates, dose, product or lot details and supporting public sources where available. Disclose relevant commercial interests. Do not fabricate, exaggerate or share another person’s identifying information.
Use “Submit a report” to contribute. Direct submissions are stored for review and are not immediately published or added to the statistics. These accounts are not medical advice or a substitute for clinical assessment.
PUBLIC POSTS & COMMENTS
Read posts and comments
Some posts and comments are found and collected automatically by a bot for convenience. Automated collection does not verify the author, product, reported experience or claim.
Loading collection…
Public anecdotal incident register
Source-read accounts. People, diagnosis and product identity remain unverified.
13 / 13 records
Research and harm reduction. Reported doses describe exposures; they are not dosing recommendations.